Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age ; volume:14 ; number:2 ; day:29 ; month:5 ; year:2013 ; pages:1 ; date:5.2013
BMC musculoskeletal disorders ; 14, Heft 2 (29.5.2013), 1, 5.2013
- Creator
-
van Gelder, C.
- Contributor
-
Kroos, M.
Özkan, L.
Plug, I.
Reuser, A.
van der Ploeg, A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2474-14-S2-P18
- URN
-
urn:nbn:de:1111-2016043026570
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van Gelder, C.
- Kroos, M.
- Özkan, L.
- Plug, I.
- Reuser, A.
- van der Ploeg, A.
- SpringerLink (Online service)
Other Objects (12)
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland